PRA traditionally focused on the second and third phase of clinical trials, which take place in hospitals, where the efficacy and possible side-effects of a drug are checked in groups of patients.” Becoming a key player in the clinical research chain It all began in Assen, where a ...
However, because this was a post hoc analysis, additional randomized clinical trials are needed to validate these findings.Similar content being viewed by others Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial Article Open...